- 908 Devices (NASDAQ:MASS +3.6%) announces that the U.S. Border Patrol selected the MX908, a handheld, battery-powered, mass spectrometry device – to standardize its trace drug detection at 20 field locations across the U.S. borders, from North to South and in the Caribbean.
- The U.S. Border Patrol purchased more than 60 MX908 units. Agency selected the MX908 to work closely with local law enforcement to prevent drug smuggling as opioid crisis rages across the country.
- The MX908 is the only technology of its kind that can detect more than 2,000 fentanyl analogs, which is critical as fentanyl and its many analogs are largely driving the opioid epidemic.